There’s been a lot of talk about a big lawsuit against Suboxone. It’s a medicine that helps people with opioid addiction by making withdrawal symptoms less painful. But some people are saying it can also cause tooth decay.
The class action lawsuit against Suboxone tooth decay involves several specific claims. Plaintiffs allege that the medication causes severe dental issues such as tooth decay, cavities, gum disease, tooth loss, oral infections, enamel erosion, and bone loss. The lawsuit claims that the manufacturers failed to provide adequate warnings about these risks, leading to significant dental harm.
Reported dental problems include tooth decay, cavities, dental abscesses/infections, tooth erosion, and total tooth loss.
These issues have been reported even in patients with no history of dental problems. The U.S. Food and Drug Administration (FDA) identified 305 cases of dental problems related to Suboxone, with 131 classified as severe.
The number of people affected by Suboxone-related dental problems is significant. In January 2022, the FDA issued a formal warning about buprenorphine dental risks, identifying 305 cases of dental problems associated with Suboxone.
Additionally, the lawsuit has gained momentum, with 142 new cases filed in January 2025, bringing the total number of lawsuits in the multidistrict litigation (MDL) to 896.
Scientific evidence supporting the claims includes a pharmacoepidemiologic study that examined the association between sublingual buprenorphine/naloxone exposure and dental disease. The study used data from the PharMetrics database, capturing patient-level data including prescriptions dispensed in the U.S. and inpatient and outpatient physician diagnoses. The study found a significant association between sublingual buprenorphine/naloxone use and dental adverse events, including dental caries and tooth loss.
Expert testimonies play a critical role in these cases.
Doctors establish a link between Suboxone and dental issues through medical evaluations and expert testimonies. These testimonies help to prove the connection between Suboxone use and the reported dental problems, supporting the plaintiffs’ claims in the lawsuit.
:
:
:
:
:
:
1trulaw.com2www.fda.gov3www.addictioncenter.com4www.millerandzois.com5jamanetwork.com6lawsuitlegit.com
The class action lawsuit against Suboxone tooth decay alleges that the medication causes severe dental issues such as tooth decay, cavities, gum disease, and tooth loss due to inadequate warnings from the manufacturers. The lawsuit has gained momentum with 896 cases filed, including 142 new cases in January 2025.
Scientific evidence supports the claims, including a pharmacoepidemiologic study that found a significant association between sublingual buprenorphine/naloxone use and dental adverse events. Expert testimonies from doctors will play a critical role in establishing a link between Suboxone use and reported dental problems.
Possible outcomes for plaintiffs include compensation for dental harm, medical expenses, and pain and suffering. Defendants may face significant financial penalties, including damages and settlements. The lawsuit could also lead to changes in the way Suboxone is marketed and prescribed, potentially affecting its users who rely on the medication for opioid addiction treatment.
The broader impact of the lawsuit could be substantial, with potential consequences for the manufacturer’s reputation, sales, and market share. If successful, the lawsuit may prompt the FDA to reevaluate the safety profile of Suboxone and consider new warnings or restrictions on its use. Ultimately, the outcome will depend on the strength of the evidence presented in court and the ability of plaintiffs to prove a causal link between Suboxone use and dental problems.